RecruitingNot ApplicableNCT06910449

Hemithoracic Arc Radiotherapy Post Pleural Decortication

Hemithoracic Volumetric Modulated Arc Radiotherapy as Part of Lung-Sparing Multimodality Therapy in Patients With Malignant Pleural Mesothelioma Phase II Trial


Sponsor

Cairo University

Enrollment

45 participants

Start Date

Nov 11, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

Malignant Pleural Mesothelioma is an aggressive and refractory disease , the most aggressive treatment plan offered to these patients include trimodalitiy approach with chemotherapy as the mainstay of treatment . the rationale of post operative Radiotherapy is to sterilize the post operative volume to reduce local failure meanwhile minimizing toxicities in this trial we are going to assess the safety and efficacy of Radiotherapy in Mesothelioma patients poat Pleural decortication


Eligibility

Min Age: 18 Years

Inclusion Criteria3

  • Evidence of metastatic disease.
  • Underwent Pleural decortication.
  • Able to provide informed consent.

Exclusion Criteria3

  • Poor pulmonary function tests.
  • Recurrent or palliative cases.
  • Inability to attend full course of Radiotherapy or follow up visits.

Interventions

RADIATIONhemithoracic Volumetric Arc Radiotherapy post Pleural decortication

post operative delivery of hemithoracic Volumetric Arc Radiotherapy


Locations(1)

national Cancer Institute Cairo university

Cairo, Fom Elkhalig, Egypt

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06910449


Related Trials